Corpus ID: 37037355

Disease Management for Adenovirus 36-Induced Obesity

@inproceedings{Zhou2017DiseaseMF,
  title={Disease Management for Adenovirus 36-Induced Obesity},
  author={B. Zhou},
  year={2017}
}
The World Health Organization (WHO) defines obesity as having a Body Mass Index (BMI) of 30 or greater [1]. In 1997, the WHO declared obesity as a global epidemic in developed and developing countries, with obesity rates continuing to increase exponentially [1]. In 1995, 200 million adults worldwide were obese and this number rapidly increased to 600 million in 2014 [1]. From 2011 to 2012, Statistics Canada estimated that 6.3 million adult Canadians are living with obesity, which suggest that… Expand

Figures and Tables from this paper

References

SHOWING 1-10 OF 23 REFERENCES
A microbiological explanation for the obesity pandemic?
  • L. Valiquette, Stéphanie Sirard, K. Laupland
  • Biology, Medicine
  • The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale
  • 2014
TLDR
The hypothesis that some individuals harbouring a microbiota more efficient at extracting energy from the diet (eg, through the ability to degrade indigestible components) may be at higher risk for obesity is interesting but controversial, and raises several questions. Expand
Longitudinal investigation of adenovirus 36 seropositivity and human obesity: the Cardiovascular Risk in Young Finns Study
TLDR
Individuals who gained weight across the life course were more likely to be Adv- 36 seropositive in adult life than those who did not gain weight, and analysis of change in weight status in relation to Adv-36 positivity did not support a causal role for Adv-37 in the development of obesity. Expand
Obesity and infection: two sides of one coin
TLDR
The aim of this paper was to review the available data regarding the various aspects of the association between obesity and infections and to highlight the possibility that infectious agents may have an etiological role in obesity, an idea known as “infectobesity”. Expand
The Microbial Hypothesis: Contributions of Adenovirus Infection and Metabolic Endotoxaemia to the Pathogenesis of Obesity
TLDR
The Faecal Microbiota Transplant for Obesity and Metabolism clinical trial is sponsoring, to study the impact of microbiome composition on weight and the association of microbes with obesity, namely, adenovirus infection and metabolic endotoxaemia is reviewed. Expand
A framework for identification of infections that contribute to human obesity.
TLDR
Clinicians should be aware of infectobesity, and its potential importance in effective obesity management, and the available information about the adipogenic human adenovirus Ad36 has been used to create a template that can be used to examine comprehensively the contributions of specific candidate microbes to human obesity. Expand
Is obesity caused by an adenovirus?
  • N. Dhurandhar
  • Biology, Medicine
  • Expert review of anti-infective therapy
  • 2012
TLDR
Adenoviruses are the only infective agents reported to be linked with adiposity in both experimental animal models and naturally infected humans, which make them promising candidates for investigating their role in human obesity. Expand
Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids
TLDR
Ad-36 is associated with increased body weight and lower serum lipids in humans and Prospective studies are indicated to determine if Ad-36 plays a role in the etiology of human obesity. Expand
The relationship between adenovirus-36 seropositivity, obesity and metabolic profile in Turkish children and adults
TLDR
The results showed that Adv36 may be an obesity agent for both adults and children, parallel with current literature data. Expand
Prophylactic and therapeutic vaccines for obesity
TLDR
The ongoing development of therapeutic vaccines to treat obesity, and the possibility of using inactivated adenovirus 36 as a vaccine and an anti-obesity agent are described. Expand
Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation.
  • Ha-Na Na, J. Nam
  • Biology, Medicine
  • The Journal of infectious diseases
  • 2012
TLDR
The proposition that virus-induced inflammation is the cellular mechanism underlying Ad36-induced obesity is supported and it is suggested that MCP-1 plays a critical role in Ad36 -induced obesity and that M CP-1 may be a therapeutic target in preventing virus- induced obesity. Expand
...
1
2
3
...